BIRC5 is a novel target of peroxisome proliferator‑activated receptor γ in brain microvascular endothelium cells during cerebral ischemia Retraction in /10.3892/mmr.2018.9418

Xu,Mingjing; Yang,Xianli; Zeng,Qing; He,He; Lu,Pengcheng; Huang,Guozhi

doi:10.3892/mmr.2017.7750

BIRC5 is a novel target of peroxisome proliferator‑activated receptor γ in brain microvascular endothelium cells during cerebral ischemia

Retraction in: /10.3892/mmr.2018.9418

Authors:
- Mingjing Xu
- Xianli Yang
- Qing Zeng
- He He
- Pengcheng Lu
- Guozhi Huang
View Affiliations

Affiliations: Department of Rehabilitation Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, P.R. China, Department of Medical Quality Management, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, P.R. China
Published online on: October 10, 2017 https://doi.org/10.3892/mmr.2017.7750
Pages: 8882-8890
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cerebral ischemia is a leading cause of ischemic stroke, which may lead to severe disability and mortality worldwide. There are some key factors concerned in cardioprotection, such as peroxisome proliferator‑activated receptor γ (PPARγ), a ligand binding transcription factor involved in various biological functions including atherosclerosis, vascular dysfunction and hypertension, and baculoviral IAP repeat‑containing 5 (BIRC5), which may protect human brain endothelial cells from ischemia‑induced apoptosis. To determine the potential roles of PPARγ in brain microvascular endothelial (bEnd.3) cells during cerebral ischemia and the relationship between PPARγ and BIRC5, a cerebral ischemia model was established with bEnd.3 cells cells by oxygen‑glucose deprivation (OGD) treatment. OGD treatment reduced proliferation and enhanced apoptosis of bEnd.3 cells in a time‑dependent manner. PPARγ expression levels were decreased in bEnd.3 cells following OGD treatment. Upregulation of PPARγ expression protected bEnd.3 cells from ischemia injury and also upregulated BIRC5 expression. PPARγ‑specific binding sites in the BIRC5 promoter were predicted bioinformatically and verified by luciferase reporter experiments. Results from electrophoretic mobility shift/supershift and chromatin immunoprecipitation assays suggested that BIRC5 may be a novel target of PPARγ transcriptional regulation during ischemic injury. The present results indicated that PPARγ may serve a protective role on bEnd.3 cells and that BIRC5 may be a downstream target of PPARγ regulation during cerebral ischemia.

View Figures

View References

1	Pan Q, He C, Liu H, Liao X, Dai B, Chen Y, Yang Y, Zhao B, Bihl J and Ma X: Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow. Mol Brain. 9:632016. View Article : Google Scholar : PubMed/NCBI
2	Xu F, Li J, Ni W, Shen YW and Zhang XP: Peroxisome proliferator-activated receptor-γ agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury. PLoS One. 8:e550802013. View Article : Google Scholar : PubMed/NCBI
3	Wu JS, Tsai HD, Cheung WM, Hsu CY and Lin TN: PPAR-γ ameliorates neuronal apoptosis and ischemic brain injury via suppressing NF-κB-Driven p22phox transcription. Mol Neurobiol. 53:3626–3645. 2016. View Article : Google Scholar : PubMed/NCBI
4	Zhang Y, Zhang X, Park TS and Gidday JM: Cerebral endothelial cell apoptosis after ischemia-reperfusion: Role of PARP activation and AIF translocation. J Cereb Blood Flow Metab. 25:868–877. 2005. View Article : Google Scholar : PubMed/NCBI
5	Fong WH, Tsai HD, Chen YC, Wu JS and Lin TN: Anti-apoptotic actions of PPAR-gamma against ischemic stroke. Mol Neurobiol. 41:180–186. 2010. View Article : Google Scholar : PubMed/NCBI
6	Ketsawatsomkron P and Sigmund CD: Molecular mechanisms regulating vascular tone by peroxisme proliferator activated receptor gamma. Curr Opin Nephrol Hyperten. 24:123–130. 2015. View Article : Google Scholar
7	Chu SF, Zhang Z, Zhang W, Zhang MJ, Gao Y, Zuo W, Huang HY and Chen NH: Upregulating the expression of survivin-HBXIP complex contributes to the protective role of IMM-H004 in transient global cerebral ischemia/reperfusion. Mol Neurobiol. 54:524–540. 2017. View Article : Google Scholar : PubMed/NCBI
8	Zhou Y, Jia S, Wang C, Chen Z, Chi Y, Li J, Xu G, Guan Y and Yang J: FAM3A is a target gene of peroxisome proliferator-activated receptor gamma. Biochim Biophysica Acta. 1830:4160–4170. 2013. View Article : Google Scholar
9	Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, et al: Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab. 27:1327–1338. 2007. View Article : Google Scholar : PubMed/NCBI
10	Wu JS, Cheung WM, Tsai YS, Chen YT, Fong WH, Tsai HD, Chen YC, Liou JY, Shyue SK, Chen JJ, et al: Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation. 119:1124–1134. 2009. View Article : Google Scholar : PubMed/NCBI
11	Fukuda S and Pelus LM: Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther. 5:1087–1098. 2006. View Article : Google Scholar : PubMed/NCBI
12	Zhang Y, Park TS and Gidday JM: Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am J Physiol Heart Circ Physiol. 292:H2573–H2581. 2007. View Article : Google Scholar : PubMed/NCBI
13	Lu M, Kwan T, Yu C, Chen F, Freedman B, Schafer JM, Lee EJ, Jameson JL, Jordan VC and Cryns VL: Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D₃ repression and cell cycle arrest. J Biol Chem. 280:6742–6751. 2005. View Article : Google Scholar : PubMed/NCBI
14	Wang Y, Tan H, Xu D, Ma A, Zhang L, Sun J, Yang Z, Liu Y and Shi G: The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells. Int J Mol Med. 34:262–268. 2014. View Article : Google Scholar : PubMed/NCBI
15	Yamashita-Sugahara Y, Tokuzawa Y, Nakachi Y, Kanesaki-Yatsuka Y, Matsumoto M, Mizuno Y and Okazaki Y: Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis. J Biol Chem. 288:4522–4537. 2013. View Article : Google Scholar : PubMed/NCBI
16	Cao G, Jiang N, Hu Y, Zhang Y, Wang G, Yin M, Ma X, Zhou K, Qi J, Yu B and Kou J: Ruscogenin attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway. Int J Mol Sci. 17:E14182016. View Article : Google Scholar : PubMed/NCBI
17	Gentil BJ, Minotti S, Beange M, Baloh RH, Julien JP and Durham HD: Normal role of the low-molecular-weight neurofilament protein in mitochondrial dynamics and disruption in charcot-marie-tooth disease. FASEB J. 26:1194–1203. 2012. View Article : Google Scholar : PubMed/NCBI
18	Ma X, Zhang H, Pan Q, Zhao Y, Chen J, Zhao B and Chen Y: Hypoxia/aglycemia-induced endothelial barrier dysfunction and tight junction protein downregulation can be ameliorated by citicoline. PLoS One. 8:e826042013. View Article : Google Scholar : PubMed/NCBI
19	Li YN, Pan R, Qin XJ, Yang WL, Qi Z, Liu W and Liu KJ: Ischemic neurons activate astrocytes to disrupt endothelial barrier via increasing VEGF expression. J Neurochem. 129:120–129. 2014. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Hussain AR, Ahmed SO, Ahmed M, Khan OS, Al Abdulmohsen S, Platanias LC, Al-Kuraya KS and Uddin S: Cross-talk between NF-κB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis. PLoS One. 7:e399452012. View Article : Google Scholar : PubMed/NCBI
22	Yin KJ, Deng Z, Hamblin M, Xiang Y, Huang H, Zhang J, Jiang X, Wang Y and Chen YE: Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci. 30:6398–6408. 2010. View Article : Google Scholar : PubMed/NCBI
23	Arsenijevic D, de Bilbao F, Plamondon J, Paradis E, Vallet P, Richard D, Langhans W and Giannakopoulos P: Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor beta-deficient mice. J Cereb Blood Flow Metab. 26:433–445. 2006. View Article : Google Scholar : PubMed/NCBI
24	Zhang Y, Wang T, Yang K, Xu J, Ren L, Li W and Liu W: Cerebral microvascular endothelial cell apoptosis after ischemia: Role of enolase-phosphatase 1 activation and aci-reductone dioxygenase 1 translocation. Front Mol Neurosci. 9:792016. View Article : Google Scholar : PubMed/NCBI
25	Sun H, Xiong W, Arrick DM and Mayhan WG: Low-dose alcohol consumption protects against transient focal cerebral ischemia in mice: Possible role of PPARγ. PLoS One. 7:e417162012. View Article : Google Scholar : PubMed/NCBI
26	Deng Y, Xiong D, Yin C, Liu B, Shi J and Gong Q: Icariside II protects against cerebral ischemia-reperfusion injury in rats via nuclear factor-κB inhibition and peroxisome proliferator-activated receptor up-regulation. Neurochem Int. 96:56–61. 2016. View Article : Google Scholar : PubMed/NCBI
27	Green DE, Sutliff RL and Hart CM: Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension? Pulm Circ. 1:33–47. 2011. View Article : Google Scholar : PubMed/NCBI
28	Mysiorek C, Culot M, Dehouck L, Derudas B, Staels B, Bordet R, Cecchelli R, Fenart L and Berezowski V: Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. Curr Neurovasc Res. 6:181–193. 2009. View Article : Google Scholar : PubMed/NCBI
29	Chen YC, Wu JS, Tsai HD, Huang CY, Chen JJ, Sun GY and Lin TN: Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders. Mol Neurobiol. 46:114–124. 2012. View Article : Google Scholar : PubMed/NCBI
30	Zeng Y, Xie K, Dong H, Zhang H, Wang F, Li Y and Xiong L: Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: Role of peroxisome proliferator-activated receptor-gamma. Brain Res. 1452:140–150. 2012. View Article : Google Scholar : PubMed/NCBI
31	Gupta D, Jetton TL, Mortensen RM, Duan SZ, Peshavaria M and Leahy JL: In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter. J Biol Chem. 283:32462–32470. 2008. View Article : Google Scholar : PubMed/NCBI
32	He F, Qu F and Song F: Aspirin upregulates the expression of neuregulin 1 and survivin after focal cerebral ischemia/reperfusion in rats. Exp Ther Med. 3:613–616. 2012. View Article : Google Scholar : PubMed/NCBI
33	Liu ZJ, Liu HQ, Xiao C, Fan HZ, Huang Q, Liu YH and Wang Y: Curcumin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury through activation of peroxisome proliferator-activated receptor-γ function. J Neurosci Res. 92:1549–1559. 2014. View Article : Google Scholar : PubMed/NCBI
34	Liu N, Zhang Y, Fan L, Yuan M, Du H, Cheng R, Liu D and Lin F: Effects of transplantation with bone marrow-derived mesenchymal stem cells modified by Survivin on experimental stroke in rats. J Transl Med. 9:1052011. View Article : Google Scholar : PubMed/NCBI
35	Fiatte C, Huin C, Collet P, Plenat F, Dauca M and Schohn H: Expression of PPARgamma is reduced by medium supplementation with L-glutamine in human colorectal Caco-2 cells. Int J Mol Med. 22:825–832. 2008.PubMed/NCBI
36	Hamy AS, Bieche I, Lehmann-Che J, Scott V, Bertheau P, Guinebretiere JM, Matthieu MC, Sigal-Zafrani B, Tembo O, Marty M, et al: BIRC5 (survivin): A pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy. Breast Cancer Res Treat. 159:499–511. 2016. View Article : Google Scholar : PubMed/NCBI
37	Lamers F, Van der Ploeg I, Schild L, Ebus ME, Koster J, Hansen BR, Koch T, Versteeg R, Caron HN and Molenaar JJ: Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe. Endocr Relat Cancer. 18:657–668. 2011. View Article : Google Scholar : PubMed/NCBI
38	Li PL, Zhang X, Wang LL, Du LT, Yang YM, Li J and Wang CX: MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Carcinogenesis. 36:1484–1493. 2015.PubMed/NCBI
39	Wang H, Zhang X, Wang L, Zheng G, Du L, Yang Y, Dong Z, Liu Y, Qu A and Wang C: Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer. J Surg Oncol. 109:574–579. 2014. View Article : Google Scholar : PubMed/NCBI
40	Wang Q, Shu R, He H, Wang L, Ma Y, Zhu H, Wang Z, Wang S, Shen G and Lei P: Co-silencing of Birc5 (survivin) and Hspa5 (Grp78) induces apoptosis in hepatoma cells more efficiently than single gene interference. Int J Oncol. 41:652–660. 2012. View Article : Google Scholar : PubMed/NCBI